Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• FanLStrasser-WeipplKLiJJBreast cancer in ChinaLancet Oncol2014157e279e28924872111
   PubMed Web of Science ®Google Scholar
• LichtensteinPHolmNVVerkasaloPKEnvironmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and FinlandN Engl J Med20003432788510891514
   PubMed Web of Science ®Google Scholar
• MichailidouKBeesleyJLindstromSGenome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerNat Genet201547437338025751625
   PubMed Web of Science ®Google Scholar
• ThompsonCBApoptosis in the pathogenesis and treatment of diseaseScience19952675203145614627878464
   PubMed Web of Science ®Google Scholar
• EvanGIVousdenKHProliferation, cell cycle and apoptosis in cancerNature2001411683534234811357141
   PubMed Web of Science ®Google Scholar
• NagataSGolsteinPThe Fas death factorScience19952675203144914567533326
   PubMed Web of Science ®Google Scholar
• KaufmannTStrasserAJostPJFas death receptor signalling: roles of Bid and XIAPCell Death Differ2012191425021959933
   PubMed Web of Science ®Google Scholar
• KimJGSohnSKChaeYSTP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatinCancer Chemother Pharmacol200964235536019052714
   PubMed Web of Science ®Google Scholar
• HagleitnerMMCoenenMJGelderblomHA first step toward personalized medicine in osteosarcoma: pharmacogenetics as predictive marker of outcome after chemotherapy-based treatmentClin Cancer Res201521153436344125829401
   PubMed Web of Science ®Google Scholar
• KangSDongSMSeoSSKimJWParkSYFAS-1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancerCancer Genet Cytogenet200818011518068525
   PubMedGoogle Scholar
• Kordi TamandaniDMSobtiRCShekariMAssociation of Fas-670 gene polymorphism with risk of cervical cancer in North Indian populationClin Exp Obstet Gynecol200835318318618754288
   PubMed Web of Science ®Google Scholar
• ZucchiFda SilvaIDRibaltaJCFas/CD95 promoter polymorphism gene and its relationship with cervical carcinomaEur J Gynaecol Oncol200930214214419480241
   PubMed Web of Science ®Google Scholar
• TanSCLetter regarding “CD95 rs1800682 polymorphism and cervical cancer risk: evidence from a meta-analysis” by Zhang et alTumour Biol201536118275827626515334
   PubMedGoogle Scholar
• CaoYMiaoXPHuangMYPolymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinomaMol Carcinog2010491194495020842669
   PubMed Web of Science ®Google Scholar
• ZhuQWangTRenJHuKLiuWWuGFAS-670A/G polymorphism: a biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese populationClin Chim Acta20104113–417918319895798
   PubMed Web of Science ®Google Scholar
• ZhangFSturgisEMSunYApoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapyInt J Cancer2015137102454246125976983
   PubMed Web of Science ®Google Scholar
• YangMSunTWangLFunctional variants in cell death pathway genes and risk of pancreatic cancerClin Cancer Res200814103230323618483392
   PubMed Web of Science ®Google Scholar
• ZhangJLiuQMaoHTAnalyzing of Fas-670 gene polymorphism in hepatocarcinoma tissueZhonghua gan zang bing za zhi2009178630631 Chinese19719928
   PubMedGoogle Scholar
• ZhouRMWangNChenZFDuanYNSunDLLiYPolymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinomaJ Gastroenterol Hepatol201025355556120074157
   PubMed Web of Science ®Google Scholar
• ByeHPrescottNJMatejcicMPopulation-specific genetic associations with oesophageal squamous cell carcinoma in South AfricaCarcinogenesis201132121855186121926110
   PubMed Web of Science ®Google Scholar
• WangSWuSMengQFAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatinSci Rep201661922926759270
   PubMed Web of Science ®Google Scholar
• CrewKDGammonMDTerryMBGenetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer riskCarcinogenesis200728122548255117962219
   PubMed Web of Science ®Google Scholar
• ZhangBSunTXueLFunctional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancerCarcinogenesis20072851067107317183065
   PubMed Web of Science ®Google Scholar
• MahfoudhWBouaouinaNGabboujSChouchaneLFASL-844 T/C polymorphism: a biomarker of good prognosis of breast cancer in the Tunisian populationHum Immunol201273993293822732091
   PubMed Web of Science ®Google Scholar
• WangWZhengZYuWLinHCuiBCaoFPolymorphisms of the FAS and FASL genes and risk of breast cancerOncol Lett20123362562822740964
   PubMed Web of Science ®Google Scholar
• HashemiMFazaeliAGhavamiSFunctional polymorphisms of FAS and FASL gene and risk of breast cancer – pilot study of 134 casesPLoS One201381e5307523326385
   PubMedGoogle Scholar
• XuYDengQHeBThe diplotype Fas-1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese womenTumour Biol20143599147916124916571
   PubMedGoogle Scholar
• ChengJZhouTLiuCProtection from Fas-mediated apoptosis by a soluble form of the Fas moleculeScience19942635154175917627510905
   PubMed Web of Science ®Google Scholar
• Sheen-ChenSMChenHSEngHLChenWJCirculating soluble Fas in patients with breast cancerWorld J Surg2003271101312557031
   PubMed Web of Science ®Google Scholar
• DaiZJLiuXHKangHFGenetic variation in metastasis-associated in colon cancer-1 and the risk of breast cancer among the Chinese Han population: a STROBE-Compliant Observational StudyMedicine2016956e280126871844
   PubMed Web of Science ®Google Scholar
• DaiZJLiuXHMaYFAssociation between single nucleotide polymorphisms in DNA polymerase kappa gene and breast cancer risk in Chinese Han population: a STROBE-Compliant Observational StudyMedicine (Baltimore)2016952e246626765445
   PubMed Web of Science ®Google Scholar
• WangMWangXFuSWSingle-nucleotide polymorphisms in PSCA and the risk of breast cancer in a Chinese populationOncotarget Epub2016330
   Google Scholar
• DupontWDPlummerWDJrPower and sample size calculations for studies involving linear regressionControl Clin Trials19981965896019875838
   PubMedGoogle Scholar
• StephensMSmithNJDonnellyPA new statistical method for haplotype reconstruction from population dataAm J Hum Genet200168497898911254454
   PubMed Web of Science ®Google Scholar
• StephensMDonnellyPA comparison of bayesian methods for haplotype reconstruction from population genotype dataAm J Hum Genet20037351162116914574645
   PubMed Web of Science ®Google Scholar
• SudaTTakahashiTGolsteinPNagataSMolecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor familyCell1993756116911787505205
   PubMed Web of Science ®Google Scholar
• GriffithTSBrunnerTFletcherSMGreenDRFergusonTAFas ligand-induced apoptosis as a mechanism of immune privilegeScience19952705239118911927502042
   PubMed Web of Science ®Google Scholar
• LeeSHShinMSParkWSAlterations of Fas (Apo-1/CD95) gene in non-small cell lung cancerOncogene199918253754376010391683
   PubMed Web of Science ®Google Scholar
• ReichmannEThe biological role of the Fas/FasL system during tumor formation and progressionSemin Cancer Biol200212430931512147205
   PubMed Web of Science ®Google Scholar
• WuJMetzCXuXA novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patientsJ Immunol2003170113213812496392
   PubMed Web of Science ®Google Scholar
• O’ConnellJBennettMWO’SullivanGCO’CallaghanJCollinsJKShanahanFExpression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilegeClin Diagn Lab Immunol19996445746310391843
   PubMedGoogle Scholar
• SibleyKRollinsonSAllanJMFunctional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemiaCancer Res200363154327433012907599
   PubMed Web of Science ®Google Scholar